@article{03aa027a589d46beaf67a52953dad0e7,
title = "The two weapons against bacterial biofilms: Detection and treatment",
abstract = "Bacterial biofilms are defined as complex aggregates of bacteria that grow attached to surfaces or are associated with interfaces. Bacteria within biofilms are embedded in a self-produced extracellular matrix made of polysaccharides, nucleic acids, and proteins. It is recognized that bacterial biofilms are responsible for the majority of microbial infections that occur in the human body, and that biofilm-related infections are extremely difficult to treat. This is related with the fact that microbial cells in biofilms exhibit increased resistance levels to antibiotics in comparison with planktonic (free-floating) cells. In the last years, the introduction into the market of novel compounds that can overcome the resistance to antimicrobial agents associated with biofilm infection has slowed down. If this situation is not altered, millions of lives are at risk, and this will also strongly affect the world economy. As such, research into the identification and eradication of biofilms is important for the future of human health. In this sense, this article provides an overview of techniques developed to detect and imaging biofilms as well as recent strategies that can be applied to treat biofilms during the several biofilm formation steps.",
keywords = "Antibiofilm agents, Antimicrobial treatment, Bacterial biofilms, Biofilm detection, Biofilm imaging",
author = "Adriana Cruz and Manuel Condinho and Beatriz Carvalho and Arraiano, {Cec{\'i}lia M.} and V{\^a}nia Pobre and Pinto, {Sandra N.}",
note = "Funding Information: Funding: This work is financed by national funds from FCT—Funda{\c c}{\~a}o para a Ci{\^e}ncia e a Tecnologia, I.P., in the scope of the project UIDB/04565/2020 and UIDP/04565/2020 of the Research Unit Institute for Bioengineering and Biosciences—iBB, project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy—i4HB, I.P. and the project MOSTMICRO-ITQB with refs UIDB/04612/2020 and UIDP/04612/2020. M.C. and A.C. are the recipients of FCT PhD fellowships (PD/BD/150602/2020 and DFA/BD/5203/2020, respectively). V.P. and S.N.P. are financed by an FCT contract according to DL57/2016 (SFRH/BPD/92409/2013 and SFRH/BPD/87188/2012, respectively). Funding Information: This work is financed by national funds from FCT?Funda??o para a Ci?ncia e a Tecnologia, I.P., in the scope of the project UIDB/04565/2020 and UIDP/04565/2020 of the Research Unit Institute for Bioengineering and Biosciences?iBB, project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy?i4HB, I.P. and the project MOSTMICRO-ITQB with refs UIDB/04612/2020 and UIDP/04612/2020. M.C. and A.C. are the recipients of FCT PhD fellowships (PD/BD/150602/2020 and DFA/BD/5203/2020, respectively). V.P. and S.N.P. are financed by an FCT contract according to DL57/2016 (SFRH/BPD/92409/2013 and SFRH/BPD/87188/2012, respectively). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = dec,
doi = "10.3390/antibiotics10121482",
language = "English",
volume = "10",
journal = "Antibiotics",
issn = "2079-6382",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",
}